LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+741.75% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 mrt 2026, 17:19 UTC

Belangrijke Nieuwsgebeurtenissen

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20 mrt 2026, 16:56 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20 mrt 2026, 16:56 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20 mrt 2026, 16:45 UTC

Belangrijke Nieuwsgebeurtenissen

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20 mrt 2026, 16:22 UTC

Belangrijke Nieuwsgebeurtenissen

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

20 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

20 mrt 2026, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

20 mrt 2026, 19:55 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20 mrt 2026, 19:28 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20 mrt 2026, 19:28 UTC

Acquisities, Fusies, Overnames

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mrt 2026, 18:39 UTC

Marktinformatie

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20 mrt 2026, 18:31 UTC

Acquisities, Fusies, Overnames

Honeywell Announces Pricing of Debt Tender Offers >HON

20 mrt 2026, 18:19 UTC

Acquisities, Fusies, Overnames

Why Mayo and Soap No Longer Mix for Unilever -- Update

20 mrt 2026, 18:15 UTC

Marktinformatie

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20 mrt 2026, 17:57 UTC

Marktinformatie

U.S. Oil Rig Count Inches Up -- Market Talk

20 mrt 2026, 17:04 UTC

Belangrijke Nieuwsgebeurtenissen

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20 mrt 2026, 16:20 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

20 mrt 2026, 16:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

20 mrt 2026, 15:40 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20 mrt 2026, 15:30 UTC

Winsten

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20 mrt 2026, 15:26 UTC

Marktinformatie

Winsten

Belangrijke Nieuwsgebeurtenissen

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20 mrt 2026, 15:26 UTC

Acquisities, Fusies, Overnames

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20 mrt 2026, 15:25 UTC

Marktinformatie

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20 mrt 2026, 15:19 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20 mrt 2026, 14:58 UTC

Belangrijke Nieuwsgebeurtenissen

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20 mrt 2026, 14:55 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Lower as Speculative Pullback Extends -- Market Talk

20 mrt 2026, 14:54 UTC

Acquisities, Fusies, Overnames

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mrt 2026, 14:53 UTC

Acquisities, Fusies, Overnames

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

20 mrt 2026, 14:46 UTC

Marktinformatie

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

20 mrt 2026, 14:45 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Koersdoel

By TipRanks

741.75% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 25 USD 741.75%

Hoogste 25 USD

Laagste 25 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celsion Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.